Tag: funds

Manila, 12 June (Globe Newswire) –  iGaming.com officially announced the publication of its updated rankings to licensed online casinos in the Philippines for 2025, providing Filipino players with new insights into regulated operators, secure platforms, and responsible gaming resources. This newly released report reflects the latest market developments and regulatory updates affecting the Philippine iGaming sector. 

VICTORIA, Seychelles, June 12, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, has unveiled a groundbreaking $100 million Guardian Fund to enhance user safety and trust across its platform. This fund is designed to provide a strong safeguard for users facing severe security threats, such as large-scale exploits, targeted attacks, or unforeseen system vulnerabilities. In a move toward greater accountability, MEXC has made the fund fully transparent by disclosing wallet addresses publicly—setting a new industry standard for proactive risk management and user protection.

Paris, France – June 12, 2025

Enterome SA, a clinical-stage company developing first-in-class OncoMimics™ immunotherapies to treat cancer, has raised $19 million in a new private financing to advance its lead clinical program EO2463 OncoMimics™ immunotherapy to treat indolent non-Hodgkin lymphoma (iNHL). The new funds will be used to expand and finalize the ongoing Phase 1/2 SIDNEY clinical trial of EO2463 and prepare the candidate for a registrational trial.

Deal to quadruple auto finance origination capacity and reduce credit application response time to a matter of seconds

New campus will expand specialty care and research for children from across the region

Alvotech (NASDAQ: ALVO, ALVO-SDB, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the completion of a private placement that was carried out on June 4, 2025, directed to Swedish and international institutional investors. About 40 institutional investors participated in the placement. About 60% of the demand came from institutional investors based in Sweden, Norway or the UK, and about 30% from US-based funds. Over 80% of the shares and Swedish Depositary Receipts (SDRs) allocated in the placement, were sold to investors that were not previously shareholders in Alvotech.